Hudson Laboratory
Location
Microbiology & Immunology
BSB B2810
General Interests
Viral Immune Evasion
View Amy Hudson Bio
Research Areas
We are interested in how viruses escape detection by the immune system.
As a response to selective pressures exerted by the host immune system, many viruses have developed an equally complex set of immunoevasive strategies. Perhaps most interesting is the array of unique strategies that viruses employ to interfere with the presentation of viral antigens on the surface of host cells for recognition by cytotoxic T lymphocytes.
Many viruses, including all known members of the Herpesvirus family, target antigen presentation by class I MHC molecules as a means of undermining the anti-viral immune response. We focus on two recently discovered human herpesviruses, HHV-6 and -7. Little is known about the immunobiology of these two beta-herpesviruses. They are most closely related to human cytomegalovirus (HCMV), and like all other herpesviruses, HHV-6 and -7 remain latent or establish persistent infections. Thus, it seemed likely that HHV-6 and -7 would also encode unique mechanisms of immune evasion. Because so many of the viral immunoevasins affect trafficking or stability of class I MHC molecules, we took a biochemical approach to examine the maturation and stability of class I molecules in HHV-7-infected T cells.
Current Members
Recent Publications
-
The Roseoloviruses Downregulate the Protein Tyrosine Phosphatase PTPRC (CD45).
(Whyte ML, Smith KA, Buchberger A, Berg Luecke L, Tjan LH, Mori Y, Gundry RL, Hudson AW.) J Virol. 2021 Jun 24;95(14):e0162820 PMID: 33952641 SCOPUS ID: 2-s2.0-85108871238 05/07/2021
-
(Hess NJ, Hudson AW, Hematti P, Gumperz JE.) J Immunol. 2020 07 01;205(1):272-281 PMID: 32444392 PMCID: PMC7329317 SCOPUS ID: 2-s2.0-85088373153 05/24/2020
-
HHV-7 U21 exploits Golgi quality control carriers to reroute class I MHC molecules to lysosomes.
(Dirck AT, Whyte ML, Hudson AW.) Mol Biol Cell. 2020 02 01;31(3):196-208 PMID: 31851583 PMCID: PMC7001482 SCOPUS ID: 2-s2.0-85081146090 12/19/2019
-
(Hess NJ, Lindner PN, Vazquez J, Grindel S, Hudson AW, Stanic AK, Ikeda A, Hematti P, Gumperz JE.) Front Immunol. 2020;11:573406 PMID: 33193358 PMCID: PMC7604455 SCOPUS ID: 2-s2.0-85094894828 11/17/2020
-
(Zumwalde NA, Sharma A, Xu X, Ma S, Schneider CL, Romero-Masters JC, Hudson AW, Gendron-Fitzpatrick A, Kenney SC, Gumperz JE.) JCI Insight. 2017 Jul 06;2(13) PMID: 28679955 PMCID: PMC5499361 SCOPUS ID: 2-s2.0-85045321193 07/07/2017
-
Natural Killer Cell Evasion Is Essential for Infection by Rhesus Cytomegalovirus.
(Sturgill ER, Malouli D, Hansen SG, Burwitz BJ, Seo S, Schneider CL, Womack JL, Verweij MC, Ventura AB, Bhusari A, Jeffries KM, Legasse AW, Axthelm MK, Hudson AW, Sacha JB, Picker LJ, Früh K.) PLoS Pathog. 2016 08;12(8):e1005868 PMID: 27580123 PMCID: PMC5006984 SCOPUS ID: 2-s2.0-84984830187 09/01/2016
-
Roseoloviruses and their modulation of host defenses.
(Hudson AW.) Curr Opin Virol. 2014 Dec;9:178-87 PMID: 25462451 SCOPUS ID: 2-s2.0-84915759618 12/03/2014
-
(May NA, Wang Q, Balbo A, Konrad SL, Buchli R, Hildebrand WH, Schuck P, Hudson AW.) J Virol. 2014 Mar;88(6):3298-308 PMID: 24390327 PMCID: PMC3957921 SCOPUS ID: 2-s2.0-84894543495 01/07/2014
-
(Kimpler LA, Glosson NL, Downs D, Gonyo P, May NA, Hudson AW.) PLoS One. 2014;9(6):e99139 PMID: 24901711 PMCID: PMC4047081 SCOPUS ID: 2-s2.0-84902477273 06/06/2014
-
Expression of CD1c enhances human invariant NKT cell activation by α-GalCer.
(Fox LM, Miksanek J, May NA, Scharf L, Lockridge JL, Veerapen N, Besra GS, Adams EJ, Hudson AW, Gumperz JE.) Cancer Immun. 2013;13:9 PMID: 23885215 PMCID: PMC3721260 SCOPUS ID: 2-s2.0-84879033899 07/26/2013
-
(Schneider CL, Hudson AW.) PLoS Pathog. 2011 Nov;7(11):e1002362 PMID: 22102813 PMCID: PMC3213103 SCOPUS ID: 2-s2.0-81755166703 11/22/2011
-
(Glosson NL, Gonyo P, May NA, Schneider CL, Ristow LC, Wang Q, Hudson AW.) J Biol Chem. 2010 Nov 19;285(47):37016-29 PMID: 20833720 PMCID: PMC2978630 SCOPUS ID: 2-s2.0-78449233108 09/14/2010